- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- January 2025
- 291 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- August 2024
- 138 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- August 2024
- 168 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- January 2025
- 388 Pages
Global
From €1915EUR$2,018USD£1,616GBP
€2554EUR$2,690USD£2,154GBP
- Report
- January 2025
- 230 Pages
United States
From €2326EUR$2,450USD£1,962GBP
€3323EUR$3,500USD£2,803GBP
- Report
- November 2024
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- April 2024
- 402 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 93 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- February 2025
- 334 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more